EcoDrugPlus

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSDNOG00000017949
Gene Symbol: NTRK3
2 Cross references
271 Possible Orthologues:

Nicastrin

Ensembl ID : ENSDNOG00000039551
Gene Symbol: NCSTN
2 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSDNOG00000049369
Gene Symbol: NAMPT
3 Cross references
234 Possible Orthologues:

Nischarin

Ensembl ID : ENSDNOG00000036637
Gene Symbol: NISCH
4 Cross references
207 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSDNOG00000013234
Gene Symbol: NOS2
2 Cross references
167 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSDNOG00000014374
Gene Symbol: NOTCH1
2 Cross references
269 Possible Orthologues:

Nuclear Factor Kappa B Subunit 1

Ensembl ID : ENSDNOG00000006855
Gene Symbol: NFKB1
2 Cross references
205 Possible Orthologues:

Nuclear Factor Kappa B Subunit 2

Ensembl ID : ENSDNOG00000032784
Gene Symbol: NFKB2
2 Cross references
124 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 2

Ensembl ID : ENSDNOG00000034506
Gene Symbol: NR1H2
2 Cross references
304 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 3

Ensembl ID : ENSDNOG00000011206
Gene Symbol: NR1H3
2 Cross references
392 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 4

Ensembl ID : ENSDNOG00000047912
Gene Symbol: NR1H4
4 Cross references
388 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 1

Ensembl ID : ENSDNOG00000010685
Gene Symbol: NR3C1
2 Cross references
280 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).